A307750 Stock Overview
Operates as a chemical total solutions provider in South Korea.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
KUKJEON PHARMACEUTICAL Co., Ltd Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩5,120.00 |
52 Week High | ₩7,480.00 |
52 Week Low | ₩4,000.00 |
Beta | -1.11 |
11 Month Change | -3.03% |
3 Month Change | -6.91% |
1 Year Change | -28.49% |
33 Year Change | -39.34% |
5 Year Change | n/a |
Change since IPO | -31.82% |
Recent News & Updates
Is KUKJEON PHARMACEUTICAL (KOSDAQ:307750) Using Too Much Debt?
Aug 07KUKJEON PHARMACEUTICAL's (KOSDAQ:307750) Problems Go Beyond Poor Profit
Mar 27Shareholder Returns
A307750 | KR Pharmaceuticals | KR Market | |
---|---|---|---|
7D | 2.4% | 3.2% | 1.9% |
1Y | -28.5% | 16.2% | 5.0% |
Return vs Industry: A307750 underperformed the KR Pharmaceuticals industry which returned 16.2% over the past year.
Return vs Market: A307750 underperformed the KR Market which returned 5% over the past year.
Price Volatility
A307750 volatility | |
---|---|
A307750 Average Weekly Movement | 6.6% |
Pharmaceuticals Industry Average Movement | 6.4% |
Market Average Movement | 6.5% |
10% most volatile stocks in KR Market | 12.1% |
10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A307750 has not had significant price volatility in the past 3 months.
Volatility Over Time: A307750's weekly volatility (7%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1972 | 167 | Jongho Hong | www.kukjeon.co.kr |
KUKJEON PHARMACEUTICAL Co., Ltd operates as a chemical total solutions provider in South Korea. It provides various chemical-based products and services; and after-sales services, such as research and development, production, quality control, and DMF services. The company manufactures active pharmaceutical ingredients; and offers molecular design and technical support.
KUKJEON PHARMACEUTICAL Co., Ltd Fundamentals Summary
A307750 fundamental statistics | |
---|---|
Market cap | ₩251.23b |
Earnings (TTM) | ₩5.35b |
Revenue (TTM) | ₩133.27b |
46.9x
P/E Ratio1.9x
P/S RatioIs A307750 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A307750 income statement (TTM) | |
---|---|
Revenue | ₩133.27b |
Cost of Revenue | ₩109.13b |
Gross Profit | ₩24.14b |
Other Expenses | ₩18.79b |
Earnings | ₩5.35b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 109.12 |
Gross Margin | 18.12% |
Net Profit Margin | 4.02% |
Debt/Equity Ratio | 73.7% |
How did A307750 perform over the long term?
See historical performance and comparison